Introduction

Transient global amnesia (TGA) is a rare neurological condition characterised by a sudden and temporary memory loss, particularly affecting the ability to form new memories (known as anterograde amnesia) and recall recent events (known as retrograde amnesia). Episodes typically last for several hours and resolve spontaneously, leaving no lasting neurological deficits.¹ While the precise etiology of TGA remains unclear, several hypotheses have been proposed, including vascular dysfunction, migraine-related mechanisms, and stress-induced factors. Among these, hormonal changes, particularly those associated with menopause, have emerged as a potential contributing factor.

Menopause represents a significant hormonal transition in women, marked by fluctuating levels of estrogen and progesterone. These hormonal changes profoundly affect various physiological systems, including the brain. Given that TGA predominantly affects individuals over the age of 50, with a slight female predominance,² it is plausible that hormonal fluctuations during menopause may play a role in its development. This article explores the relationship between hormonal changes and TGA, focusing on the mechanisms by which menopause-related hormonal fluctuations may influence memory processes and susceptibility to TGA episodes.

Understanding transient global amnesia

TGA is characterised by a sudden onset of memory loss without other neurological symptoms such as paralysis or impaired consciousness. Patients remain alert and oriented but repeatedly ask questions about their surroundings and recent events due to their inability to retain new information.³ The condition typically resolves within 24 hours, leaving patients with no recollection of the episode itself.

The incidence of TGA is estimated at 3–8 cases per 100,000 people annually, with most cases occurring in individuals aged 50–70 years.² Some studies suggest a slight female predominance, particularly during the perimenopausal and postmenopausal years. This demographic pattern has raised questions about whether hormonal changes associated with ageing and menopause may contribute to TGA.

Hormonal Changes During Menopause is defined as the cessation of menstrual cycles due to ovarian failure, typically occurring between the ages of 45 and 55. This transition is accompanied by dramatic fluctuations in sex hormone levels, particularly estrogen and progesterone. Estrogen plays critical roles in regulating cardiovascular health, bone density, mood stability, and cognitive function. Its decline during menopause can lead to symptoms such as hot flashes, sleep disturbances, mood swings, and cognitive changes.

Estrogen also exerts significant effects on brain function. It modulates neurotransmitter systems (e.g., serotonin and acetylcholine), promotes synaptic plasticity in the hippocampus, a key region for memory formation, and influences cerebral blood flow.⁵ These effects suggest that hormonal fluctuations during menopause may disrupt normal brain function and increase susceptibility to conditions like TGA.

Mechanisms linking hormonal changes to TGA

Several mechanisms have been proposed to explain how hormonal changes during menopause might contribute to TGA:

Vascular effects

Estrogen has protective effects on the cardiovascular system. It promotes vasodilation by increasing nitric oxide production and reducing inflammation in blood vessels. The decline in estrogen during menopause may impair cerebral blood flow regulation and vascular reactivity. Studies have shown that TGA episodes are often associated with transient disruptions in cerebral blood flow within the hippocampus⁽³⁾. These vascular changes may be exacerbated by hormonal fluctuations during menopause.

Hippocampal function

The hippocampus is rich in estrogen receptors and plays a central role in memory formation. Estrogen enhances synaptic plasticity and neurogenesis in the hippocampus. Its decline during menopause may impair hippocampal function, making individuals more vulnerable to memory disturbances like TGA. Neuroimaging studies have identified selective dysfunction of CA1 neurons in the hippocampus during TGA episodes,³ suggesting that hormonal changes could exacerbate this vulnerability.

Neurotransmitter modulation

Estrogen influences neurotransmitter systems involved in memory and cognition. For example, it enhances acetylcholine activity in the brain, whilst modulating serotonin and dopamine pathways.¹ Fluctuations in these neurotransmitters during menopause could disrupt neural signalling involved in memory processes, potentially contributing to TGA episodes.

Stress response

Hormonal changes affect the hypothalamic-pituitary-adrenal (HPA) axis, which regulates stress responses. Menopause-related fluctuations in cortisol levels may increase susceptibility to stress-induced conditions like TGA. Emotional arousal has been identified as a common trigger for TGA episodes, suggesting that altered stress reactivity during menopause could play a role.

Migraine susceptibility

Migraine has been proposed as a potential risk factor for TGA due to shared mechanisms involving vascular dysfunction and cortical spreading depression. Hormonal changes during menopause are known to increase migraine susceptibility in some women. This heightened vulnerability may indirectly contribute to TGA risk.

Evidence supporting the hormonal hypothesis

Several lines of evidence support the hypothesis that hormonal changes play a role in TGA:

Age and gender distribution

The higher incidence of TGA among individuals over age 50 aligns with the typical age range for menopause. The slight female predominance further suggests a potential link between hormonal factors and TGA susceptibility.²

Case reports

Case studies have documented instances of TGA occurring shortly after initiation or cessation of hormone replacement therapy (HRT), suggesting that abrupt hormonal shifts may act as triggers for TGA episodes.

Neuroimaging findings

Functional neuroimaging studies have revealed transient disruptions in hippocampal blood flow during TGA episodes.³ These findings are consistent with vascular changes associated with estrogen decline during menopause.

Experimental evidence

Animal studies have demonstrated that estrogen deprivation impairs hippocampal plasticity and memory function.⁴ These findings provide a biological basis for understanding how menopausal hormonal changes might contribute to memory disturbances like TGA.

Challenges in current research

Despite growing interest in the role of hormones in TGA, several challenges remain:

1. Rarity of TGA: The low incidence of TGA makes it difficult to conduct large-scale studies
2. Complex Etiology: The multifactorial nature of TGA complicates efforts to isolate specific contributions from hormonal factors
3. Methodological Variability: Differences in diagnostic criteria and hormone measurement techniques make it challenging to compare findings across studies
4. Lack of Longitudinal Data: Most research on TGA has been cross-sectional rather than longitudinal

Implications for diagnosis and treatment

Understanding the role of hormones in TGA has important implications for clinical practice:

1. Diagnostic Awareness: Clinicians should consider menopausal hormonal fluctuations as potential risk factors when evaluating middle-aged women presenting with transient memory loss
2. Hormonal Profiling: Assessing hormone levels during or after a TGA episode could provide valuable insights into individual susceptibility
3. Hormone Replacement Therapy: While HRT may offer cognitive benefits by stabilising estrogen levels, its use must be carefully weighed against potential risks
4. Lifestyle Interventions: Stress reduction techniques and dietary modifications aimed at improving vascular health could help mitigate menopausal effects on brain function

Future research directions

To better understand the relationship between hormones and TGA:

1. Longitudinal studies tracking hormone levels over time are needed
2. Advanced neuroimaging techniques could elucidate how hormonal fluctuations affect hippocampal function
3. Genetic studies exploring individual differences in hormone sensitivity may identify specific risk factors for TGA
4. Clinical trials evaluating targeted interventions such as HRT or stress management strategies could provide evidence-based approaches for reducing risk

Summary

Transient global amnesia remains an enigmatic condition with complex underlying mechanisms. While its exact cause is unknown, evidence suggests that hormonal changes, particularly those associated with menopause, may play a significant role by influencing vascular function, hippocampal plasticity, neurotransmitter balance, stress reactivity, and migraine susceptibility.

Further research into this relationship has the potential to improve our understanding of both TGA and broader interactions between hormones and brain health. By integrating insights from neurology, endocrinology, and cognitive science, we can develop more effective strategies for diagnosing, managing, and preventing this intriguing condition.